Bibliography
Studies by this author
3 studies attributed to Andrea Wang‐Gillam on the platform. Click a card to read the full analysis.
A pilot study of liposomal irinotecan plus 5-FU/LV combined with paricalcitol in patients with advanced pancreatic cancer whose disease progressed on gemcitabine-based therapy.
Pilot study assessing safety and preliminary efficacy of adding paricalcitol to liposomal irinotecan plus 5-FU/LV in patients with advanced pancreatic cancer whose disease progressed on gemcitabine-based therapy.
Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma
Retrospective review of vitamin D status and prognosis in patients with pancreatic adenocarcinoma at a single U.S. cancer center (2007–2011).
A pilot study of paricalcitol plus nanoliposomal irinotecan and 5-FU/LV in advanced pancreatic cancer patients after progression on gemcitabine-based therapy
Single-institution, open-label pilot trial evaluating safety and preliminary efficacy of adding paricalcitol (a vitamin D analogue) to nanoliposomal irinotecan plus 5-FU/LV in patients with advanced pancreatic cancer who progressed on gemcitabine-based therapy. Not retracted; no corrections reported.